Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition
Related Experiment Video
Updated: Feb 11, 2026

In Vitro and In Vivo Models to Study Corneal Endothelial-mesenchymal Transition
Published on: August 20, 2016
Mark Lipphardt1,2, Hassan Dihazi2, Noo Li Jeon3
1Departments of Medicine, Pharmacology and Physiology, Renal Research Institute, New York Medical College at Touro University, Valhalla, NY, USA.
Background:
Our laboratory has previously demonstrated that Sirt1endo-/- mice show endothelial dysfunction and exaggerated renal fibrosis, whereas mice with silenced endothelial transforming growth factor beta (TGF-β) signaling are resistant to fibrogenic signals. Considering the fact that the only difference between these mutant mice is confined to the vascular endothelium, this indicates that secreted substances contribute to these contrasting responses.
Methods:
We performed an unbiased proteomic analysis of the secretome of renal microvascular endothelial cells (RMVECs) isolated from these two mutants. We cultured renal fibroblasts and RMVECs and used microfluidic devices for coculturing.
Results:
Dickkopf-3 (DKK3), a putative ligand of the Wnt/β-catenin pathway, was present exclusively in the fibrogenic secretome. In cultured fibroblasts, DKK3 potently induced myofibroblast activation. In addition, DKK3 antagonized effects of DKK1, a known inhibitor of the Wnt pathway, in conversion of fibroblasts to myofibroblasts. In RMVECs, DKK3 induced endothelial-mesenchymal transition and impaired their angiogenic competence. The inhibition of endothelial outgrowth, enhanced myofibroblast formation and endothelial-mesenchymal transition were confirmed in coculture. In reporter DKK3-eGFP × Col3.6-GFPcyan mice, DKK3 was marginally expressed under basal conditions. Adriamycin-induced nephropathy resulted in upregulation of DKK3 expression in tubular and, to a lesser degree, endothelial compartments. Sulindac sulfide was found to exhibit superior Wnt pathway-suppressive action and decreased DKK3 signals and the extent of renal fibrosis.
Conclusions:
In conclusion, this unbiased proteomic screen of the profibrogenic endothelial secretome revealed DKK3 acting as an agonist of the Wnt pathway, enhancing formation of myofibroblasts and endothelial-mesenchymal transition and impairing angiogenesis. A potent inhibitor of the Wnt pathway, sulindac sulfide, suppressed nephropathy-induced DKK3 expression and renal fibrosis.
Insights
Dickkopf-3 (DKK3) promotes kidney fibrosis by activating Wnt signaling, leading to myofibroblast formation and endothelial dysfunction. Sulindac sulfide, a Wnt inhibitor, reduced DKK3 and fibrosis in nephropathy.
Area of Science:
- Renal pathophysiology
- Endothelial biology
- Molecular signaling
Background:
- Sirt1endo-/- mice exhibit endothelial dysfunction and renal fibrosis.
- Endothelial transforming growth factor beta (TGF-β) signaling inhibition confers resistance to fibrosis.
- Contrasting responses suggest secreted factors from endothelium play a key role.
Purpose of the Study:
- To identify secreted factors from renal microvascular endothelial cells (RMVECs) that contribute to renal fibrosis.
- To investigate the role of Dickkopf-3 (DKK3) in mediating endothelial dysfunction and fibrosis.
Main Methods:
- Unbiased proteomic analysis of RMVEC secretomes from mutant mice.
- In vitro culture of renal fibroblasts and RMVECs.
- Microfluidic co-culture devices.
- In vivo studies using reporter mice and adriamycin-induced nephropathy model.
Main Results:
- DKK3, a Wnt/β-catenin pathway ligand, was exclusively found in the fibrogenic secretome.
- DKK3 induced myofibroblast activation in fibroblasts and antagonized DKK1 effects.
- DKK3 promoted endothelial-mesenchymal transition and impaired angiogenesis in RMVECs.
- DKK3 expression was upregulated in nephropathy; sulindac sulfide suppressed DKK3 and fibrosis.
Conclusions:
- DKK3 is a profibrogenic endothelial secretome component that activates Wnt signaling.
- DKK3 promotes myofibroblast formation and endothelial-mesenchymal transition, impairing angiogenesis.
- Wnt pathway inhibition via sulindac sulfide ameliorates DKK3-induced renal fibrosis.
More Related Videos
07:05TGF-β-mediated Endothelial to Mesenchymal Transition EndMT and the Functional Assessment of EndMT Effectors using CRISPR/Cas9 Gene Editing
Published on: February 26, 2021
08:38Author Spotlight: A Neonatal Heterotopic Rat Heart Transplantation Model for the Study of Endothelial-to-Mesenchymal Transition
Published on: July 21, 2023
Related Concept Videos
Cooperative Allosteric Transitions
Phase Transitions
ortho–para-Directing Activators: –CH3, –OH, –⁠NH2, –OCH3
Properties of Transition Metals
Phase Transitions: Vaporization and Condensation
Phase Transitions: Sublimation and Deposition